Benign neoplasm: Uterine tubes and ligaments

CD2_BENIGN_UTERINE_TUBES_LIGAMENTS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions None	313377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D28.7& Hospital discharge: ICD-9 — 2210 Hospital discharge: ICD-8 — 2210 Cause of death: ICD-10 — D28.7& Cause of death: ICD-9 — 2210 Cause of death: ICD-8 — 2210 2 out of 7 registries used, show all original rules.	236
4. Check minimum number of events None	236
5. Include endpoints None	236
6. Filter based on genotype QC (FinnGen only)	219

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D28
Name in latin: Neoplasma benignum alterius organi genitalis feminini specificati

NAME	CD2_BENIGN_UTERINE_TUBES_LIGAMENTS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D287
HD_ICD_9	2210
HD_ICD_8	2210
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D287
COD_ICD_9	2210
COD_ICD_8	2210
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Uterine tubes and ligaments based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1728	1728	-
Only index persons	1555	1555	-
Unadjusted period prevalence (%)
Whole population	0.05	0.05	-
Only index persons	0.06	0.06	-
Median age at first event (years)
Whole population	-	39.39	-
Only index persons	-	37.97	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	219	219	-
Unadjusted period prevalence (%)	0.08	0.08	-
Median age at first event (years)	36.38	36.38	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
222: Matched controls
2220

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

22101

ICD-8 Finland

Benign neoplasm of other female genital organs, Fallopian tube and broad ligament

+∞

127.8

110

2210A

ICD-9 Finland

Benign neoplasm of other female genital organs, Fallopian tube and uterine ligaments

+∞

70.7

D28.7

ICD-10 Finland

Benign neoplasm: Other specified female genital organs

+∞

43.1

8204

FHL

Salpingo-oophorectomy

10.8

9.7

8201

FHL

Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis

6.6

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019225) pH of Specimen

192

2.32

5.00

2.8

3.7

7.30

7.36

0.47

128

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

136

1654

0.54

4.52

21.2

20.6

13.79

13.75

0.13

136

1637

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

257

2.00

3.90

6.2

5.1

33.84

33.38

0.13

154

(3044889) 12 lead EKG panel

129

1510

0.65

2.46

4.2

4.3

—

0.40

—

(3022313) Gas panel - Capillary blood

2.35

2.40

3.5

3.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

5.65

2.22

1.4

1.1

—

(3018418) pH of Serum or Plasma

767

0.65

2.02

3.4

3.8

7.40

0.17

539

(3013512) EKG study

779

1.41

1.72

3.8

3.6

—

0.83

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

1.70

0.0

2.1

—

7.52

—

(4024509) Urine culture

113

1.85

1.67

2.5

1.9

—

(3028626) Oxygen [Partial pressure] in Capillary blood

2.33

1.58

2.0

2.3

7.74

7.92

kpa

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.01

1.52

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

956

0.73

1.42

2.4

1.9

1.21

1.30

mmol/l

0.61

785

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

500

1.39

2.1

2.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.94

1.31

2.1

1.8

—

(3021901) Oxygen saturation in Capillary blood

2.33

1.28

1.4

2.0

90.02

90.66

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.96

1.25

1.1

1.3

—

(40768804) Tissue Pathology biopsy report

105

898

1.32

1.25

2.3

2.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

832

1.32

1.22

4.1

4.0

26.58

31.82

ng/l

0.27

624

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

172

1589

1.37

1.13

5.2

4.7

12.60

13.55

mm/h

0.41

159

1465

(40768443) Skin Pathology biopsy report

113

1.65

1.09

1.2

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

877

0.77

1.07

2.8

3.1

2.35

2.37

mmol/l

0.65

794

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

2.16

1.06

1.3

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

2.30

1.04

1.2

1.3

—

94.40

—

(4146454) Self-monitoring of blood glucose

2.20

0.98

1.8

2.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

351

1.35

0.98

2.4

13.07

12.69

umol/l

0.15

328

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

204

1954

1.54

0.97

16.8

16.5

18.36

21.16

mg/l

0.70

164

1605

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

109

960

1.27

0.97

2.5

2.8

—

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

669

1.28

0.96

2.1

2.4

—

(3002582) Erythrocytes [#/volume] in Urine

732

0.77

0.95

3.7

3.4

18.07

46.15

e6/l

1.73

560

(3030467) Casts [#/volume] in Urine by Automated count

634

0.77

0.91

3.6

3.3

0.19

0.46

e6/l

1.82

457

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

270

0.68

0.85

2.5

1.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

314

1.33

0.84

2.3

2.4

21.54

21.46

0.01

290

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

784

0.79

0.84

3.6

3.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1.90

0.82

1.2

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

279

0.69

0.82

2.4

1.8

—

(3022621) pH of Urine by Test strip

191

1.41

0.81

2.8

2.4

5.97

6.12

0.33

131

(3007461) Platelets [#/volume] in Blood

215

2098

1.79

0.80

26.1

25.4

256.63

258.42

e9/l

0.17

210

2055

(3026361) Erythrocytes [#/volume] in Blood

215

2099

1.77

0.80

26.0

25.4

4.41

4.37

e12/l

0.68

209

2047

(3010813) Leukocytes [#/volume] in Blood

215

2099

1.77

0.80

26.1

25.4

6.49

6.59

e9/l

0.36

209

2046

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.79

0.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.2

—

102.50

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.5

—

(21494434) Karyotype in Bone marrow

0.00

0.79

0.0

1.1

—

(3015736) pH of Urine

105

937

1.23

0.78

3.7

4.1

6.19

6.33

0.53

514

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

538

0.77

0.78

2.6

2.44

2.46

mmol/l

0.63

481

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

396

0.75

0.76

4.1

2.9

0.92

1.13

e6/l

0.21

205

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

439

0.76

0.75

3.5

4.4

2555.15

116.69

ng/l

0.49

353

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

119

1079

1.22

0.75

2.6

2.5

84.01

82.17

nmol/l

0.26

110

970

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

2.02

0.73

1.4

1.5

1214.00

151.28

u/ml

—

(40758558) Short blood count panel - Blood

689

0.80

0.71

7.5

6.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

199

1916

1.37

0.70

15.5

16.4

76.04

76.00

ml/min/173m2

0.01

187

1787

(3021601) Nitrite [Presence] in Urine by Test strip

127

1165

1.21

0.69

3.9

4.5

0.00

estimate

-0.00

242

(3019550) Sodium [Moles/volume] in Serum or Plasma

210

2041

1.53

0.69

18.6

19.8

139.94

139.80

mmol/l

0.30

203

1997

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

212

2065

1.59

0.68

13.4

12.8

24.46

23.24

u/l

0.59

204

1998

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

713

1.21

0.68

2.6

2.3

82.62

62.18

u/l

0.59

655

(3023103) Potassium [Moles/volume] in Serum or Plasma

210

2044

1.51

0.65

18.8

19.9

3.94

3.95

mmol/l

0.24

203

1994

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

121

1.44

0.64

3.1

2.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

353

0.76

0.63

3.7

3.1

6.93

4.90

e6/l

0.23

161

(3018095) Leukocytes [#/volume] in Urine

835

0.83

0.63

4.4

4.2

360.82

101.24

e6/l

0.37

579

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1.62

0.63

1.6

2.2

25.77

25.47

mmol/l

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

122

1.43

0.62

1.2

1.4

—

55.19

—

(3011288) Drugs identified in Urine by Screen method Nominal

0.00

0.60

0.0

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

330

1.26

0.60

2.3

2.36

2.37

g/l

0.06

303

(3035350) Ketones [Presence] in Urine by Test strip

127

1175

1.19

0.60

4.1

4.6

0.00

13.84

estimate

0.80

253

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

198

1918

1.30

0.54

7.4

6.7

39.22

39.54

mmol/mol

0.27

188

1790

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.61

0.53

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

127

1185

1.17

0.51

4.1

4.5

0.00

estimate

-0.00

235

(3020564) Creatinine [Moles/volume] in Serum or Plasma

212

2076

1.47

0.51

22.2

71.52

71.19

umol/l

0.09

207

2046

(3002030) Lymphocytes/Leukocytes in Blood

108

996

1.16

0.50

7.6

5.9

30.35

28.13

1.52

102

930

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

264

1.25

0.49

6.9

7.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

697

0.85

0.49

2.2

2.8

34.32

29.25

u/l

0.46

647

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.49

0.48

3.7

2.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

241

0.77

0.46

1.5

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

241

0.77

0.46

1.5

1.6

—

(3037756) Immunofixation for Serum or Plasma

1.44

0.46

1.1

2.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

535

0.85

0.43

1.5

1.3

4.63

2.35

u/ml

—

145

(3002523) Influenza virus A Ag [Presence] in Specimen

1.58

0.42

1.4

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.58

0.42

1.4

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.45

0.42

1.3

—

(3019069) Monocytes/Leukocytes in Blood

106

987

1.14

0.41

7.7

6.0

8.56

8.70

0.26

913

(3012441) Differential panel - Pleural fluid

0.00

0.41

0.0

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.41

0.0

1.3

—

(3004775) Volume in Urine collected for unspecified duration

0.00

0.41

0.0

3.1

—

582.55

—

(3016750) Collection duration of Urine

0.00

0.41

0.0

2.6

—

463.27

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.41

0.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.41

0.0

2.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

224

1.23

0.41

2.0

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

112

1192

0.88

0.40

5.1

5.9

9.51

10.05

umol/l

0.42

104

1123

(3002256) Pathology report gross observation

280

1.21

0.40

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

102

0.68

0.40

2.1

1.8

—

(3020891) Body temperature

106

1.34

0.40

4.3

4.1

37.02

36.94

°c

1.40

106

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.40

0.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

716

0.87

0.39

3.8

3.5

—

(3010421) pH of Blood

1.34

0.38

1.4

2.3

7.41

7.42

—

(3029937) Albumin [Presence] in Urine by Test strip

658

1.14

0.37

4.2

4.7

0.06

0.00

estimate

0.48

232

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

197

1923

1.22

0.36

7.3

6.3

1.84

1.92

mu/l

0.50

179

1775

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1.28

0.36

1.3

1.6

82.78

184.46

ug/l

—

(40768793) Breast Pathology biopsy report

1.35

0.36

1.6

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

727

1.13

0.36

3.0

2.1

130.28

150.03

u/l

0.27

686

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

205

2010

1.26

0.35

6.8

6.4

2.77

2.74

mmol/l

0.21

191

1848

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

553

1.14

0.35

2.9

2.3

2.96

3.14

mg/l

0.29

477

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

453

0.86

0.35

1.3

1.5

—

(3022145) Colonoscopy Study observation

274

0.82

0.35

1.6

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.36

0.34

2.7

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

323

1.17

0.34

1.5

1.4

146.67

653.18

titre

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

198

0.79

0.34

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.31

0.33

1.0

1.5

—

(3022096) Basophils/Leukocytes in Blood

105

989

1.12

0.32

7.8

5.9

0.80

0.74

0.63

909

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.32

0.32

1.1

1.2

—

1.51

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

501

0.87

0.31

1.6

1.7

1.01

1.21

mg/l

0.38

406

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.31

0.30

1.3

—

(3003694) ABO and Rh group [Type] in Blood

541

0.88

0.30

1.3

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.28

0.30

1.1

1.5

—

(4035726) Immunohistochemistry procedure

216

0.82

0.29

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

106

0.75

0.29

1.0

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

717

1.11

0.29

3.0

3.2

1098.70

1108.54

ng/l

0.01

623

(3007164) IgA [Mass/volume] in Serum or Plasma

456

0.88

0.28

2.1

1.5

2.69

2.42

g/l

0.34

262

(3004588) Protein electrophoresis panel - Serum or Plasma

159

1.21

0.28

1.3

2.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.26

0.28

1.5

1.3

—

(3019977) pH of Arterial blood

256

0.84

0.27

5.7

6.7

7.44

7.42

0.76

151

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.31

0.26

1.6

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

234

0.84

0.26

2.1

2.4

4.20

6.08

umol/l

2.24

205

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

190

1861

1.15

0.25

5.2

4.5

1.27

1.25

mmol/l

0.17

173

1689

(3019198) Lymphocytes [#/volume] in Blood

115

1099

1.10

0.25

7.6

5.6

1.92

1.98

e9/l

0.20

101

962

(3006504) Eosinophils/Leukocytes in Blood

104

990

1.10

0.25

7.8

5.8

3.04

2.77

0.65

914

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.28

0.25

1.8

1.4

—

(3006315) Basophils [#/volume] in Blood

113

1082

1.09

0.23

7.5

5.7

0.05

0.04

e9/l

0.58

920

(3023183) Ammonium ion [Moles/volume] in Plasma

1.32

0.23

1.6

22.40

30.33

umol/l

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.29

0.23

3.0

3.3

28.46

60.76

u/ml

—

(3001604) Monocytes [#/volume] in Blood

112

1073

1.09

0.23

7.6

5.7

0.55

0.56

e9/l

0.07

913

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

874

1.09

0.22

3.8

4.5

0.00

0.01

estimate

0.50

196

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

135

1.20

0.22

2.2

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

1.22

0.22

1.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.19

0.21

1.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

201

1980

1.16

0.21

6.1

5.4

4.76

4.80

mmol/l

0.25

189

1826

(3013115) Eosinophils [#/volume] in Blood

116

1115

1.08

0.21

7.6

5.9

0.21

0.18

e9/l

1.10

101

963

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.21

0.0

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.21

0.0

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.05

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.21

0.0

1.4

—

146.36

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3013727) Leukocytes other/Leukocytes in Blood

0.00

0.21

0.0

4.3

—

43.75

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.21

0.0

2.5

—

1.10

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

221

1.15

0.21

2.2

3.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

0.21

0.0

1.3

—

(3017704) Immunofixation for Urine

0.00

0.21

0.0

2.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

142.97

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.20

0.0

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.20

0.0

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.20

0.0

1.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.20

0.0

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

759

0.92

0.19

3.5

3.1

6.30

6.38

mmol/l

0.07

617

(3021879) Hepatitis B virus core Ab [Presence] in Serum

132

0.82

0.19

1.5

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

166

1.16

0.18

1.3

—

(40761511) CBC panel - Blood by Automated count

198

2006

0.88

0.18

14.8

14.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.21

0.18

1.0

1.2

—

(3008898) HLA-B27 [Presence]

1.11

0.17

1.0

1.1

—

(4034850) Laboratory test

1.11

0.17

7.3

9.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

0.75

0.17

2.4

1.2

—

142.86

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

127

1233

1.07

0.16

4.6

4.7

6.65

6.64

mmol/l

0.03

120

1157

(42529406) Shigella sp [Presence] in Stool by Culture

0.75

0.16

1.5

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.75

0.16

1.5

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.74

0.15

1.5

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

687

1.07

0.15

1.8

1.7

21.97

21.98

nmol/l

0.00

583

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

122

1185

1.07

0.15

4.7

6.1

1.22

mmol/l

0.59

105

1022

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

192

0.88

0.15

1.7

2.7

71.58

61.57

ml/min/173m2

1.03

(3000494) Fungus identified in Specimen by Culture

285

0.90

0.15

1.6

1.4

—

(36660697) Celiac disease serology panel - Serum

171

0.87

0.15

1.2

—

(40761536) Microorganisms panel - Urine sediment

171

0.87

0.15

2.9

4.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.10

0.15

1.2

—

(3026782) Osmolality of Urine

416

0.92

0.13

1.9

3.0

482.94

482.03

mosm/kgh2o

0.01

370

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

199

1968

1.11

0.13

6.3

5.5

5.79

5.93

mmol/l

1.14

183

1799

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

110

1069

1.06

0.13

4.9

5.5

1.22

mmol/l

0.34

983

(3019309) Folate [Moles/volume] in Red Blood Cells

405

1.08

0.13

1.6

1.7

1264.77

1269.13

nmol/l

0.01

301

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

148

0.87

0.13

1.1

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

123

1.15

0.13

1.3

1.0

—

(3025159) Blasts/Leukocytes in Blood

189

0.89

0.12

5.1

4.6

0.14

0.24

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

100

971

1.05

0.12

3.6

3.0

104.74

95.42

ug/l

0.33

893

(3026008) Bacteria identified in Urine by Culture

818

0.95

0.12

3.9

3.3

—

(3000492) Spirometry study

182

1.11

0.11

1.3

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

348

1.08

0.11

1.4

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

108

1108

0.95

0.11

2.9

2.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

467

1.06

0.11

1.9

1.7

376.51

19730212.83

pmol/l

0.50

370

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

115

1.14

0.11

1.2

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

361

0.93

0.10

2.2

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

482

0.94

0.10

4.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

429

1.06

0.10

1.3

15.98

12.64

u/ml

0.09

162

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.11

0.10

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.11

0.10

1.4

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

173

1710

1.05

0.08

6.1

5.0

14.92

14.99

pmol/l

0.14

156

1566

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

185

0.91

0.08

1.7

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

129

1268

1.04

0.08

3.2

3.1

65.89

47.25

u/l

0.62

119

1182

(3049717) Cytology report of Urine Cyto stain

1.10

0.08

2.6

—

(3003396) Base excess in Arterial blood by calculation

256

0.93

0.08

5.3

6.6

1.69

1.35

mmol/l

0.09

220

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

254

1.07

0.08

3.8

4.1

6.46

8.92

ug/l

0.30

210

(3001019) Free T4 and TSH panel - Serum or Plasma

1.03

0.07

1.3

1.8

—

(3019150) Specific gravity of Urine by Refractometry

522

1.05

0.07

5.0

4.8

1.02

kg/l

1.10

346

(3019832) Treponema pallidum Ab [Presence] in Serum

0.85

0.07

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.87

0.07

2.1

1.5

—

(3032080) INR in Blood by Coagulation assay

102

1001

1.04

0.06

12.1

12.3

1.21

1.19

inr

0.11

819

(3011397) Hemoglobin [Presence] in Urine by Test strip

563

1.04

0.06

4.9

4.3

—

0.13

—

(3020682) Albumin/Creatinine [Ratio] in Urine

757

0.97

0.06

4.0

3.9

6.13

6.00

mg/mmol

0.01

414

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

129

1.09

0.06

5.0

6.2

27.31

25.05

mmol/l

0.73

129

(3021589) Normoblasts [#/volume] in Blood

947

0.97

0.05

10.5

11.5

0.00

e9/l

1.06

777

(3002179) Metamyelocytes/Leukocytes in Blood

181

0.93

0.05

4.4

4.2

0.25

0.85

—

(3041096) Erythrocytes [Presence] in Urine by Automated

614

0.97

0.04

2.6

3.9

0.00

estimate

-0.00

196

(40768797) Stomach Pathology biopsy report

328

1.04

0.04

1.5

1.2

—

(3025941) Bacteria identified in Stool by Culture

129

0.93

0.03

1.2

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

181

1.05

0.03

4.7

4.3

0.11

0.16

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

101

1021

0.98

0.03

2.4

2.2

104.08

100.39

pmol/l

0.29

467

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

470

0.97

0.03

1.4

37.26

35.31

iu/ml

0.05

165

(3012516) Albumin [Mass/volume] in Urine

740

0.98

0.02

3.4

3.3

22.20

26.89

mg/l

0.18

429

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

162

1629

0.98

0.02

8.1

7.8

81.66

79.95

u/l

0.13

151

1527

(3004716) Salmonella sp identified in Stool by Organism specific culture

117

0.94

0.02

2.3

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

121

1217

0.99

0.01

9.6

9.1

4.04

3.97

e9/l

0.12

104

1064

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

174

1.04

0.00

2.8

1.5

—

(3012544) pH of Venous blood

234

1.03

0.00

2.4

3.0

7.40

7.39

0.29

131

(3026493) Urate [Moles/volume] in Serum or Plasma

536

0.99

0.00

2.1

2.6

338.98

327.76

umol/l

0.42

465

(3017181) Myelocytes/Leukocytes in Blood

193

0.98

0.00

4.7

4.2

0.78

0.91

—

(3042936) Bacteria identified in Isolate by Culture

295

0.98

0.00

1.8

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

275

0.98

0.00

2.3

2.0

122.33

120.97

ug/g

0.01

214

(3023368) Bacteria identified in Blood by Culture

565

0.99

0.00

3.9

3.8

—

(21494755) Public health laboratory ask at order entry panel

105

1.05

0.00

1.2

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

188

1.01

0.00

1.3

3.3

16.68

39.32

u/ml

1.80

182

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

197

1968

1.01

0.00

6.3

5.3

1.57

1.62

mmol/l

0.90

183

1807

(3000991) Gas panel - Venous blood

188

1.01

0.00

4.4

6.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.91

0.00

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.91

0.00

1.6

1.3

—

(3033799) Differential panel - Peritoneal fluid

0.00

-0.00

0.0

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

10.4

—

0.68

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

7.71

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

0.91

-0.00

1.3

1.8

3.66

2.23

mg/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

-0.00

0.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.86

-0.00

2.0

5.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

0.62

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.00

-0.00

0.0

35.6

—

89.29

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

71.98

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.4

—

4.81

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

114.33

—

(3023383) Lactate [Moles/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

4.86

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

2.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.87

-0.00

1.0

1.2

—

37.33

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

0.00

-0.00

0.0

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1.00

-0.00

1.0

1.1

3.38

4.01

mmol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1425.20

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

2.1

—

67.21

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1.00

-0.00

1.2

1.1

—

11.23

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

-0.00

0.0

1.2

—

226.12

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.00

-0.00

1.4

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(40768446) Kidney Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.00

-0.00

1.3

1.9

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

-0.00

0.0

2.3

—

1.16

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.4

—

10.96

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_UTERINE_TUBES_LIGAMENTS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_UTERINE_TUBES_LIGAMENTS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_UTERINE_TUBES_LIGAMENTS – Benign neoplasm: Uterine tubes and ligaments

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Uterine tubes and ligaments

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints